Antibodies are referred as a Y-shaped glycoproteins produce by the adaptive immune system (B-cells) that bind specific antigens with high affinity and making them effective in the treatment of various types of diseases such as cancer, and inflammatory diseases. One of the major factors driving the growth of the antibody market is the increasing prevalence of various types of cancer among people worldwide.